CORONA Remedies2201.80
+32.20 (+1.48%)

CORONA Remedies Share Price

2201.80+32.20 (+1.48%)
+53.07% past 1 Year

Corporate filings & documents

Announcements

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd Sage Investment Trust & Anchor Partners
1 day ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd Sage Investment Trust & Anchor Partners
1 day ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd Sage Investment Trust & Anchor Partners
1 day ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd Sage Investment Trust & Anchor Partners
1 day ago
Intimation of participation in Analyst / Investor meet
2 days ago
Intimation of participation in Analyst / Investor meet
2 days ago
Reply to Clarification
1 week ago
Reply to Clarification
1 week ago
The Exchange has sought clarification from Corona Remedies Ltd on September 10 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
1 week ago
The Exchange has sought clarification from Corona Remedies Ltd on September 10 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
1 week ago
Intimation of participation in Analyst / Investor Conference
1 month ago
Intimation of participation in Analyst / Investor Conference
1 month ago
Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the first quarter and three months ended June 30 2026
1 month ago
Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the first quarter and three months ended June 30 2026
1 month ago
Intimation for Schedule of Analysts / Investor Conference
1 month ago
Intimation for Schedule of Analysts / Investor Conference
1 month ago
Audio Recording of Q1 FY27 Earnings Conference Call with Analysts / Investors
1 month ago
Audio Recording of Q1 FY27 Earnings Conference Call with Analysts / Investors
1 month ago
Newspaper Publication of Unaudited Financial Results for the first quarter and three months ended June 30 2026
1 month ago
Newspaper Publication of Unaudited Financial Results for the first quarter and three months ended June 30 2026
1 month ago
Analyst/Investor presentation
1 month ago
Analyst/Investor presentation
1 month ago
Press Release on Financial Results for Q1FY27
1 month ago
Press Release on Financial Results for Q1FY27
1 month ago
Unaudited Financial Results for the first quarter and three months ended June 30 2026
1 month ago
Unaudited Financial Results for the first quarter and three months ended June 30 2026
1 month ago
Outcome of Board Meeting
1 month ago
Outcome of Board Meeting
1 month ago
Intimation for Schedule of Analysts / Investor Conference
2 months ago
Intimation for Schedule of Analysts / Investor Conference
2 months ago
Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve Unaudited Financial Results on Standalone and Consolidated Basis for First Quarter and Three Months ended June 30 2026
2 months ago
Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve Unaudited Financial Results on Standalone and Consolidated Basis for First Quarter and Three Months ended June 30 2026
2 months ago
Declaration of Voting Results and Scrutinizers Report for 22nd Annual General Meeting
2 months ago
Declaration of Voting Results and Scrutinizers Report for 22nd Annual General Meeting
2 months ago
Outcome of 22nd Annual General Meeting
2 months ago
Outcome of 22nd Annual General Meeting
2 months ago
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the first quarter ended June 30 2026
2 months ago
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the first quarter ended June 30 2026
2 months ago
Press Release for Commencement of Commercial Production
2 months ago
Press Release for Commencement of Commercial Production
2 months ago
Intimation under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015-Commencement of Commercial Production
2 months ago
Intimation under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015-Commencement of Commercial Production
2 months ago
Intimation of Closure of Trading Window for dealing in securities of CORONA Remedies Limited in terms of SEBI (Prohibition of Insider Trading) Regulations 2015
2 months ago
Intimation of Closure of Trading Window for dealing in securities of CORONA Remedies Limited in terms of SEBI (Prohibition of Insider Trading) Regulations 2015
2 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd & Others
3 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd & Others
3 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd & Others
3 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd & Others
3 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Invesco Mutual Fund
3 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Invesco Mutual Fund
3 months ago

Annual reports

Empty box

No annual reports found

Concalls & investor presentations

Aug 2026
ConcallPresentation
Jul 2026
May 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Feb 2026
Jan 2026
ConcallPresentation

CORONA Remedies Ltd Share Price Today

The CORONA Remedies Ltd share price today is ₹2096.90. During the trading session, the CORONA Remedies Ltd share price opened at ₹2100.00 and recorded an intraday high of ₹2108.60 and a low of ₹2082.30. Last closing price was ₹2100.10. Over the past 52 weeks, the CORONA Remedies Ltd share price has ranged between ₹1336.60 and ₹2270.10. The current CORONA Remedies Ltd stock price reflects real-time market activity based on executed trades on the exchange.